CORC

在结果中检索

CORC

浏览/检索结果: 共32条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Beam Instrumentation System for Shanghai Soft X-ray FEL Test Facility 会议论文
Brazil, 2020
作者:  L.W. Lai;  F.Z. Chen;  J. Chen;  J. Chen;  W. Fang
收藏  |  浏览/下载：8/0  |  提交时间：2021/05/25
Single acousto-optic tunable filter based double filtering imaging system 会议论文
Shanghai, China, 2019-03-17
作者:  Zhang, Xiaofa;  Sheng, Zhenfei;  Chen, Yaqi;  Zhang, Chunguang;  Wang, Hao
收藏  |  浏览/下载：62/0  |  提交时间：2019/08/14
Single acousto-optic tunable filter based double filtering imaging system 会议论文
Shanghai, China, March 17-20, 2019
作者:  Yu, Jiaying;  Lai, Rongcheng;  Zeng, Xueqing;  Zheng, Ruoling;  Huang, Xiaoli
收藏  |  浏览/下载：64/0  |  提交时间：2019/08/18
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Single acousto-optic tunable filter based double filtering imaging system 会议论文
Shanghai, China, March 17-20, 2019
作者:  Zhang, Xiaofa;  Sheng, Zhenfei;  Chen, Yaqi;  Zhang, Chunguang;  Wang, Hao
收藏  |  浏览/下载：25/0  |  提交时间：2019/08/18
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace